• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Total number of webinars, teleconferences, and other meetings conducted with Center for Disease Control (CDC), Substance Abuse and Mental Health Services Administration (SAMHSA), and other federal partners in the month

Dictionary: The primary objectives of stakeholder meetings are to share information so that the mission of the Center for Tobacco Products is recognized, understood and supported to the maximum extent possible.

Information is current as of March 18, 2015

Fiscal Year - 2015

Skip graphic and jump to text data

TimeTargetNumber
Oct 2014N/A5
Nov 2014N/A5
Dec 2014N/A3
Jan 2015N/ATBD
Feb 2015N/ATBD
Mar 2015N/ATBD
Apr 2015N/ATBD
May 2015N/ATBD
Jun 2015N/ATBD
Jul 2015N/ATBD
Aug 2015N/ATBD
Sep 2015N/ATBD

FY 2015 YTD: 13

Total number of webinars, teleconferences, and other meetings conducted with State, Territorial, Local, and Tribal tobacco control programs and other non-federal government partners and stakeholders in the month

Fiscal Year - 2015

Skip graphic and jump to text data

TimeTargetNumber
Oct 2014N/A1
Nov 2014N/A0
Dec 2014N/A2
Jan 2015N/ATBD
Feb 2015N/ATBD
Mar 2015N/ATBD
Apr 2015N/ATBD
May 2015N/ATBD
Jun 2015N/ATBD
Jul 2015N/ATBD
Aug 2015N/ATBD
Sep 2015N/ATBD

FY 2015 YTD: 3

Total number of webinars, teleconferences, and other meetings conducted with non-governmental stakeholders in the month

Fiscal Year - 2015

Skip graphic and jump to text data

TimeTargetNumber
Oct 2014N/A9
Nov 2014N/A5
Dec 2014N/A4
Jan 2015N/ATBD
Feb 2015N/ATBD
Mar 2015N/ATBD
Apr 2015N/ATBD
May 2015N/ATBD
Jun 2015N/ATBD
Jul 2015N/ATBD
Aug 2015N/ATBD
Sep 2015N/ATBD

FY 2015 YTD: 18

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.